Endocrine gland-derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome in women undergoing controlled ovarian hyperstimulation

Fertility and Sterility

Volumn 95, Issue 2, 2011, Pages 673-678

  Gao, Min Zhi ^a,b   Zhao, Xiao Ming ^a   Sun, Zhao Gui ^c   Hong, Yan ^a   Zhao, Lei Wen ^a   Zhang, Hui Qin ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI INSTITUTE OF PLANNED PARENTHOOD RESEARCH   (China)

Author keywords

controlled ovarian hyperstimulation; Endocrine gland derived vascular endothelial growth factor; ovarian hyperstimulation syndrome; ovarian response; vascular endothelial growth factor

Indexed keywords

CHORIONIC GONADOTROPIN; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; ESTRADIOL;

ADULT; ARTICLE; DISEASE SEVERITY; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OVARY FOLLICLE FLUID; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; CASE-CONTROL STUDIES; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR FLUID; HUMANS; INFERTILITY; OSMOLAR CONCENTRATION; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; PROGNOSIS; RETROSPECTIVE STUDIES; SERUM; VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED; YOUNG ADULT;

EID: 78751575273     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2010.09.044     Document Type: Article

References (26)

1. A. Delvigne, and S. Rozenberg Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review Hum Reprod Update 8 2002 559 577
2. C.E. Busso, J. Garcia-Velasco, R. Gomez, C. Alvarez, C. Simon, and A. Pellicer Symposium: Update on prediction and management of OHSS prevention of OHSS-dopamine agonists Reprod Biomed Online 19 2009 43 51
3. L.C. Foong, B. Bhagavath, J. Kumar, and S.C. Ng Ovarian hyperstimulation syndrome is associated with reversible impairment of vascular reactivity Fertil Steril 78 2002 1159 1163
4. U. Elchalal, and J.G. Schenker The pathophysiology of ovarian hyperstimulation syndrome - views and ideas Hum Reprod 12 1997 1129 1137
5. D.O. Bates, and S.J. Harper Regulation of vascular permeability by vascular endothelial growth factors Vascul Pharmacol 39 2002 225 237
6. L.C. Ajonuma Is vascular endothelial growth factor (VEGF) the main mediator in ovarian hyperstimulation syndrome (OHSS)? Med Hypotheses 70 2008 1174 1178
7. D. Manau, F. Fabregues, J. Penarrubia, M. Creus, F. Carmona, and G. Casals Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF Hum Reprod 22 2007 669 675
8. R. Mathur, G. Hayman, A. Bansal, and J. Jenkins Serum vascular endothelial growth factor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome in highly responsive women undergoing assisted conception Fertil Steril 78 2002 1154 1158
9. J. LeCouter, J. Kowalski, J. Foster, P. Hass, Z. Zhang, and L. Dillard-Telm Identification of an angiogenic mitogen selective for endocrine gland endothelium Nature 412 2001 877 884
10. J. LeCouter, and N. Ferrara EG-VEGF and the concept of tissue-specific angiogenic growth factors Semin Cell Dev Biol 13 2002 3 8
11. L. Negri, R. Lattanzi, E. Giannini, and P. Melchiorri Bv8/Prokineticin proteins and their receptors Life Sci 81 2007 1103 1116
12. N. Ferrara, J. LeCouter, R. Lin, and F. Peale EG-VEGF and Bv8: a novel family of tissue-restricted angiogenic factors Biochim Biophys Acta 1654 2004 69 78
13. J. LeCouter, R. Lin, and N. Ferrara Endocrine gland-derived VEGF and the emerging hypothesis of organ-specific regulation of angiogenesis Nat Med 8 2002 913 917
14. S. Battersby, H.O. Critchley, K. Morgan, R.P. Millar, and H.N. Jabbour Expression and regulation of the prokineticins (endocrine gland-derived vascular endothelial growth factor and Bv8) and their receptors in the human endometrium across the menstrual cycle J Clin Endocrinol Metab 89 2004 2463 2469
15. H.M. Fraser, J. Bell, H. Wilson, P.D. Taylor, K. Morgan, and R.A. Anderson Localization and quantification of cyclic changes in the expression of endocrine gland vascular endothelial growth factor in the human corpus luteum J Clin Endocrinol Metab 90 2005 427 434
16. A. Golan, R. Ron-el, A. Herman, Y. Soffer, Z. Weinraub, and E. Caspi Ovarian hyperstimulation syndrome: an update review Obstet Gynecol Surv 44 1989 430 440
17. J. Plendl Angiogenesis and vascular regression in the ovary Anat Histol Embryol 29 2000 257 266
18. G. Gutman, V. Barak, S. Maslovitz, A. Amit, J.B. Lessing, and E. Geva Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis Fertil Steril 89 2008 922 926
19. N. Ferrara, G. Frantz, J. LeCouter, L. Dillard-Telm, T. Pham, and A. Draksharapu Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries Am J Pathol 162 2003 1881 1893
20. T. Kisliouk, H. Podlovni, K. Spanel-Borowski, O. Ovadia, Q.Y. Zhou, and R. Meidan Prokineticins (endocrine gland-derived vascular endothelial growth factor and BV8) in the bovine ovary: expression and role as mitogens and survival factors for corpus luteum-derived endothelial cells Endocrinology 146 2005 3950 3958
21. D. Maldonado-Perez, J. Evans, F. Denison, R.P. Millar, and H.N. Jabbour Potential roles of the prokineticins in reproduction Trends Endocrinol Metab 18 2007 66 72
22. T. Kisliouk, N. Levy, A. Hurwitz, and R. Meidan Presence and regulation of endocrine gland vascular endothelial growth factor/prokineticin-1 and its receptors in ovarian cells J Clin Endocrinol Metab 88 2003 3700 3707
23. S.R. Soares, R. Gomez, C. Simon, J.A. Garcia-Velasco, and A. Pellicer Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome Hum Reprod Update 14 2008 321 333
24. A. Pellicer, C. Albert, A. Mercader, F. Bonilla-Musoles, J. Remohi, and C. Simon The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor Fertil Steril 71 1999 482 489
25. Y.A. Koo, B. Lee, H.J. Park, J. Choi, E. Lee, and D. Choi Altered vascular endothelial growth factor expression during GnRH antagonist protocol in women of reproductive age with normal baseline hormone profiles Fertil Steril 91 2009 744 748
26. E. Pau, I. Alonso-Muriel, R. Gómez, E. Novella, A. Ruiz, and J.A. García-Velasco Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome Hum Reprod 21 2006 1453 1460